The Australasian Professional Society on Alcohol and other Drugs

News & Media

The Neuroscience Interest Group of International Society of Addiction Medicine (ISAM-NIG)

New monthly talk series, In love with addiction neuroscience

ISAM talk series1

For further information and to register for future talks visit their website

You can find the full recorded video of the first talk on the ISAM-NIG channel, and the slides from clicking on this link.

Invitation to participate in an Update of the National Comorbidity Guidelines

The Matilda Centre for Research in Mental Health and Substance Use at the University of Sydney has been funded by the Australian Government Department of Health to update and revise the ‘Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings’ (second edition).
Originally published in 2009, with the second edition released in 2016, this hugely popular resource aimed to provide alcohol and other drug (AOD) workers with evidence-based information on the management of comorbid mental health conditions in AOD settings. Since publication of the second edition in July 2016, 15,000 hard and electronic copies have been distributed to clinicians and treatment services across Australia.
Subsequent funding from the Australian Government Department of Health enabled the development of an accompanying online training program and interactive online copy of the second edition. Since the website and online training program were launched in November 2017, close to 3,500 people have begun using the program and more than 650 people have completed the full training program. The website has attracted a monthly average of approximately 3,000 visitors (>5,650 per month in 2020).
The revision of the second edition will bring the Guidelines up to date with the most current evidence. The project is being undertaken by Dr Christina Marel, Prof Katherine Mills, Dr Alana Fisher, Ms Erin Madden, Prof Maree Teesson, Dr Mark Deady, Prof Frances Kay-Lambkin, Prof Amanda Baker, Prof Andrew Baillie, and Prof Kevin Gournay.
The revision team would be delighted if members of the alcohol and other drugs sector would be interested in participating in the revision through one (or more) of the following:

  1. Attending one of online two discussion forums;
  2. Completing a short online survey;
  3. Emailing feedback about the Guidelines directly to our team.

Online discussion forums
The revision team are holding two online discuss forums open to anyone, and hope that that these forums will be attended by a variety of interested stakeholders including alcohol and other drug workers, clinicians, healthcare workers, consumers and people with lived experience of mental health and substance use, family members, carers as well as academic experts. Additional discussion forums may be made available depending on demand.
The discussion forums will be held online on
Discussion Forum 1: Tuesday 8 September 2020, from 1 to 4pm AEST,and
Discussion Forum 2: Thursday 10 September 2020, from 9am to 12pm AEST.
During the forums, discussion will include the content of the Guidelines with a particular focus on how the existing resource can be improved. A copy of the current edition of the Guidelines is available for download on the Comorbidity Guidelines website:
If you are interested in participating as a discussion forum member in either forum, please register below.
Register for Discussion Forum 1: Tuesday 8 September 2020, from 1 to 4pm AEST
Register for Discussion Forum 2: Thursday 10 September 2020, from 9am to 12pm AEST  
Online survey
The online survey will take around 5 minutes to complete, and will focus on the current (2nd edition) Guidelines, and areas for improvement.

The survey will remain open until 5pm (AEST) 30th September 2020.
Click here to complete the online survey:
Send feedback directly to us
We also welcome any other form of feedback that can be sent directly to our team.
Please email This email address is being protected from spambots. You need JavaScript enabled to view it. before 5pm (AEST) 30th September 2020


Job Opportunity with South Eastern Sydney Local Health District (SESLHD)

Senior Allied Health Manager - Drug And Alcohol Services - Langton Centre

Organisation/Entity: South Eastern Sydney Local Health District
Job Category:
  • Health - Allied | Health Clinician
Job Location:
  • Sydney Region
Job Reference Number: REQ177137
Work Type: Full-Time
Total Remuneration Package: $125832 - $129030
Closing Date: 09/09/2020 - 11:59 PM
Employment Type: Permanent Full Time
Position Classification: Dietitian Level 6, Exercise Physiologist Level 6, Occupational Therapist Level 6, Orthoptist Level 6, Physiotherapist Level 6, Podiatrist Level 6, Social Worker Level 6, Speech Pathologist Level 6 and Senior Clinical Psychologist
Remuneration: $125,832 - $132,111 per annum
Hours Per Week: 38
Requisition ID: REQ177137

What you'll be doing
The vision for South Eastern Sydney Local Health District (SESLHD) is ‘exceptional care, healthier lives’. SESLHD is committed to enabling our community to be healthy and well, and to providing the best possible compassionate care when people need it.
The Senior Allied Health Manager, Drug and Alcohol (D&A) services will provide operational leadership and guidance and oversee a range of Allied Health models within SESLHD Drug & Alcohol Service. They will facilitate the implementation of high level clinical expertise in order to provide high quality care to patients/clients and their carers consistent with NSW Ministry of Health (MoH) and South Eastern Sydney Local Health District (SESLHD) policies, procedures and standards. The position contributes directly to the development of policy, with consideration of the strategic context.
This position has professional accountability for the Allied Health service within the SESLHD Drug & Alcohol Services facility and reports operationally to the Director Drug & Alcohol Services General Manger or delegate and has professional accountability to the SESLHD Allied Health Discipline Advisor of their discipline. 
SESLHD is committed to creating a workplace that reflects the diversity of our community. This will help ensure our employees, our patients and their carers, feel supported . We encourage people from different backgrounds to apply.

Employment of a temporary visa holder may only occur if no suitable permanent resident or citizen of Australia has been identified for this position following suitable labour market testing.

Selection Criteria:

  1. Relevant tertiary qualification in an Allied Health discipline, or a fully registered psychologist, with demonstrated expertise of health policy, priorities and treatment in relation to the drug and alcohol field.
  2. Demonstrated high level management experience in a health care environment.
  3. Extensive experience in providing psychosocial services relevant to drug and alcohol patients with complex clinical presentations.
  4. Demonstrated ability to provide high level clinical support, training and supervision to professional, technical and support staff.
  5. Excellent negotiation, decision making and advocacy skills including the ability to interact constructively and collaboratively with a diverse range of stakeholders, throughout all organisational levels.
  6. Demonstrated experience of working as part of a multi-disciplinary team and applying independent professional judgement when dealing with situations of a complex nature.
  7. Demonstrated experience of initiating, leading, completing and disseminating quality improvement, service evaluation processes and research activities.
  8. Demonstrated experience in writing reports, briefings and other correspondence.

Need more information?
  1) Click here for the Position Description and SESLHD Expected Standards
  2) Find out more about applying for this position
For role related queries or questions contact Nicholas Lintzeris on This email address is being protected from spambots. You need JavaScript enabled to view it.

Applications Close: 9 September 2020  


HPCA is seeking applications from registered NSW physicians and psychiatrists to become health assessors

HPCA is seeking applications from registered drug and alcohol psychiatry and physicians specialising in drug and alcohol dependence assessment and treatment located in NSW to become health assessors on the Council Directed Health Assessment List (the List).

The List includes health assessors who may be engaged to assess the health of registered health practitioners under the Health Practitioner Regulation National Law (NSW). Health assessors provide assessment reports that assist the health professional councils and impaired registrants panels to determine if a registered health practitioner is impaired under the National Law (NSW). If a registered health practitioner is impaired, further action may be recommended by the health assessor. This includes restrictions on practice and other options available to the relevant health professional council.

The List has been established to support the timely and flexible provision of health assessments across NSW. You can apply, via a single application process to work with all 15 health professional councils in NSW.You can apply for the List at any time, however in order to be considered for the first round, your application will need to be submitted by COB 31 August 2020.


For further information on how to apply and to complete an application form, visit


The APSAD podcast series ‘Thoughts of Substance’ is calling for Interviewees

 The new season of Thoughts of Substance is in development by the Early to Mid-Career subcommittee. We would like to hear from EMCR and PhD students who would be interested in taking part in the podcast series. This is an opportunity to highlight a great piece of research you are working on, and to share your career experiences thus far. 
Interviews will be conducted by members of the subcommittee, running for approx. 15 – 20 minutes. If you are interested in taking part in the Thoughts of Substance podcast or have any questions please contact This email address is being protected from spambots. You need JavaScript enabled to view it. or reach out to members of the EMCR subcommittee
You can access all episodes from season 1 Thoughts of Substance via the APSAD website where we heard from past APSAD Early Career Award winner discuss how their careers have evolved, and their current work.If you any recommendations or have a topic you would like to hear about please feel free to reach out to members of the EMCR subcommittee or send an email to This email address is being protected from spambots. You need JavaScript enabled to view it.
Thought of Substance podcast slide

Listserv for APSAD EMCR and Student Members

 This newly developed listserv has been established by the APSAD Early-Mid Career Researcher (EMCR) subcommittee to facilitate member communication and the sharing of information and opportunities for all APSAD EMCR and Student Members. Join in the conversation with other APSAD EMCR and Student members where you can share relevant news and opportunities.

Are you an APSAD Member interested in joining the APSAD EMCR Network Listserv, send an email This email address is being protected from spambots. You need JavaScript enabled to view it. to join. 

Members should familiarise themselves with the EMCR Listserv Standards of Conduct before posting, and ensure the Standards are followed.This Listserv is not moderated and messages posted represent only the views of the individuals posting. APSAD does not endorse the accuracy of any "statements"

Members can opt-out of the listserv at any time by clicking the 'opt-out' link at the end of every listserv email. 


Webinar: ClinTrial Refer: A New APProach to Increasing Cross-Referral and Recruitment to Clinical Trials


clintrial refer app logoClinTrial Refer: A New APProach to Increasing Cross-Referral and Recruitment to Clinical Trials

When: 13.00 (AEST) Thursday 16 July

Presenter: Mrs Christine Zahren, Business Development Manager, ClinTrial Refer

Clinical Trial Refer (CTR), a mobile app and website platform, that helps connect patients and clinicians to current clinical trials, facilitating the connection of individuals to studies with interventions that may help them.

The NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN) invested in the CTR app to enable Addiction Medicine clinicians to enhance client access to clinical trials. Learn how to connect your patients to relevant trials via the CTR app.


Register in advance for this webinar. After registering, you will receive a confirmation email containing information about joining the webinar.


APSAD Student Membership is now FREE

Access member-only benefits and resources without barriers

APSAD understands the difficulty students face around limited funding and the need to have a support network and recognise that students are the future of the alcohol and other drug sector. Providing free membership allows students studying in Australia and New Zealand to access member-only benefits and resources without barriers.

Student members have access to exclusive Early to Mid Career Researchers (EMCR) events, networking, mentoring, advice and guidance, supporting our Student Members, through a range of membership activities and benefits.

Help spread the word amongst your networks, information on how to apply and eligibility for student membership can be found on our membership page.




ASCP Webinars: July - September Webinar Details

ASCP banner

12.00 (AEST) Tuesday 28 July 2020 l  Add to Calendar

The Utilisation, Effectiveness & Safety of Smoking Cessation Pharmacotherapies During Pregnancy: An Australian Population-Based Study

Presenter: Alys Havard, Senior Research Fellow, Centre for Big Data Research in Health, University of NSW

This NHMRC-funded research used linked pharmaceutical claims and administrative health data for all women who gave birth in New South Wales and Western Australia between 2004 and 2012 to examine the extent to which prescription NRT patches, bupropion and varenicline are used during pregnancy. To examine the effectiveness of these medicines during pregnancy, the smoking cessation rates associated with varenicline relative to NRT patch use was measured. The risk and benefits associated with these medicines in pregnancy was assessed by comparing the rate of adverse birth outcomes among women who used prescription NRT patches, bupropion or varenicline with the rate among women who smoked but did not receive any of these medicines.

Register in advance for this webinar:

After registering, you will receive a confirmation email containing information about joining the webinar.


12.00 (AEST) Tuesday 25 August 2020 l Add to Calendar

An Evaluation of Online and Automated Smoking Cessation Programs

Presenter: Prof Ron Borland, Deputy Director, Melbourne Centre for Behaviour Change, School of Psychological Sciences, University of Melbourne

There is now a plethora of online smoking cessation apps and programs, most completely unevaluated and often not based on strong theoretical principles. This presentation will focus on what works and which might be available to Australian smokers. In particular, I will describe the characteristics of the QuitCoach (which I developed), the strong evidence base behind it, and the key techniques that appear to be behind its effectiveness. I will also discuss how automated resources might be used as complements to person-delivered resources, especially for smokers with more than average needs for help.

Register in advance for this webinar:

After registering, you will receive a confirmation email containing information about joining the webinar.


12.00 (AEST) Tuesday 29 September 2020 l Add to Calendar

ASCP Webinar: Smoke screen: A novel approach to promoting smoke free pregnancy

Presenter: Nancy Westcott, Manager Statewide Smoking Cessation Program, Alcohol and Drug Service, Tasmanian Health Service

A Quality Improvement Activity undertaken by the Smoking Cessation Program at the Royal Hobart Hospital that involved carbon monoxide monitoring, demonstrated an eight-fold increase in referral of pregnant women to cessation services. This enabled funding to be secured for an ethics approved, one-year pilot project (the first of its kind in Australia) to explore the effectiveness on an opt-out routine CO monitoring model within a Midwifery Group Practice cohort of 500 women. Tune in to hear how it all about it!

Register in advance for this webinar:

After registering, you will receive a confirmation email containing information about joining the webinar.



ASCP Webinar: Smoking and the Course of COVID: Clear or Mud?

ASCP banner

12.00 (AEST) Tuesday 30 June 2020 

ASCP Webinar: Smoking and the Course of COVID – Clear or Mud?

Presenter: Professor Matther Peters AM, Respiratory Physician and Head of Respiratory Medicine at Concord Hospital

Details of the presentation will be provided shortly.

Register in advance for this webinar:

After registering, you will receive a confirmation email containing information about joining the webinar